Meanwhile, hyperglycemia and tumor necrosis factor-α (TNF-α) decrease androgen receptors through nuclear factor kappa B (NF-kB) (Barbosa-Desongles et al., 2013), thereby reducing the risk of prostate cancer. Here, NFKB1 is linked to prostate carcinoma.